343 related articles for article (PubMed ID: 30673276)
21. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution.
Saravanakumar G; Min KH; Min DS; Kim AY; Lee CM; Cho YW; Lee SC; Kim K; Jeong SY; Park K; Park JH; Kwon IC
J Control Release; 2009 Dec; 140(3):210-7. PubMed ID: 19560497
[TBL] [Abstract][Full Text] [Related]
22. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
23. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C
Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304
[TBL] [Abstract][Full Text] [Related]
24. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
25. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
[TBL] [Abstract][Full Text] [Related]
26. Genipin-stabilized caseinate-chitosan nanoparticles for enhanced stability and anti-cancer activity of curcumin.
Razi MA; Wakabayashi R; Tahara Y; Goto M; Kamiya N
Colloids Surf B Biointerfaces; 2018 Apr; 164():308-315. PubMed ID: 29413610
[TBL] [Abstract][Full Text] [Related]
27. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel.
Yang X; Cai X; Yu A; Xi Y; Zhai G
J Colloid Interface Sci; 2017 Jun; 496():311-326. PubMed ID: 28237749
[TBL] [Abstract][Full Text] [Related]
28. Characterization and carboplatin loaded chitosan nanoparticles for the chemotherapy against breast cancer in vitro studies.
Khan MA; Zafaryab M; Mehdi SH; Quadri J; Rizvi MM
Int J Biol Macromol; 2017 Apr; 97():115-122. PubMed ID: 28082219
[TBL] [Abstract][Full Text] [Related]
29. Redox-responsive paclitaxel-pentadecanoic acid conjugate encapsulated human serum albumin nanoparticles for cancer therapy.
Zhang Y; Wang J; Xing H; Liu C; Li X
Int J Pharm; 2023 Mar; 635():122761. PubMed ID: 36822341
[TBL] [Abstract][Full Text] [Related]
30. Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo.
Zhang JY; He B; Qu W; Cui Z; Wang YB; Zhang H; Wang JC; Zhang Q
J Microencapsul; 2011; 28(6):528-36. PubMed ID: 21702701
[TBL] [Abstract][Full Text] [Related]
31. Enhancement of the targeting capabilities of the Paclitaxel-loaded pluronic nanoparticles with a glycol chitosan/heparin composite.
Yuk SH; Oh KS; Cho SH; Kim SY; Oh S; Lee JH; Kim K; Kwon IC
Mol Pharm; 2012 Feb; 9(2):230-6. PubMed ID: 22149139
[TBL] [Abstract][Full Text] [Related]
32. Polyelectrolyte three layer nanoparticles of chitosan/dextran sulfate/chitosan for dual drug delivery.
Wang F; Li J; Tang X; Huang K; Chen L
Colloids Surf B Biointerfaces; 2020 Jun; 190():110925. PubMed ID: 32155455
[TBL] [Abstract][Full Text] [Related]
33. Green synthesis, formulation and biological evaluation of a novel ZnO nanocarrier loaded with paclitaxel as drug delivery system on MCF-7 cell line.
Akbarian M; Mahjoub S; Elahi SM; Zabihi E; Tashakkorian H
Colloids Surf B Biointerfaces; 2020 Feb; 186():110686. PubMed ID: 31816463
[TBL] [Abstract][Full Text] [Related]
34. Characteristics, Cryoprotection Evaluation and In Vitro Release of BSA-Loaded Chitosan Nanoparticles.
Yan Q; Weng J; Wu X; Wang W; Yang Q; Guo F; Wu D; Song Y; Chen F; Yang G
Mar Drugs; 2020 Jun; 18(6):. PubMed ID: 32549252
[TBL] [Abstract][Full Text] [Related]
35. Self-Assembly of Porphyrin-Paclitaxel Conjugates Into Nanomedicines: Enhanced Cytotoxicity due to Endosomal Escape.
Zheng X; Li Z; Chen L; Xie Z; Jing X
Chem Asian J; 2016 Jun; 11(12):1780-4. PubMed ID: 27124552
[TBL] [Abstract][Full Text] [Related]
36. Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery.
Yu X; Hou J; Shi Y; Su C; Zhao L
Int J Nanomedicine; 2016; 11():6035-6046. PubMed ID: 27881917
[TBL] [Abstract][Full Text] [Related]
37. Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer.
Yang H; Tang C; Yin C
Acta Biomater; 2018 Jun; 73():400-411. PubMed ID: 29660508
[TBL] [Abstract][Full Text] [Related]
38. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
[TBL] [Abstract][Full Text] [Related]
39. pH-responsive stearic acid-O-carboxymethyl chitosan assemblies as carriers delivering small molecular drug for chemotherapy.
Luo F; Fan Z; Yin W; Yang L; Li T; Zhong L; Li Y; Wang S; Yan J; Hou Z; Zhang Q
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110107. PubMed ID: 31546448
[TBL] [Abstract][Full Text] [Related]
40. Interaction of bovine serum albumin with self-assembled nanoparticles of 6-O-cholesterol modified chitosan.
Li X; Chen M; Yang W; Zhou Z; Liu L; Zhang Q
Colloids Surf B Biointerfaces; 2012 Apr; 92():136-41. PubMed ID: 22178440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
